Equitable Trust CO Bio Techne Corp Transaction History

Equitable Trust CO

$1.47 Billion
Q3 2024

A detailed history of Equitable Trust CO transactions in Bio Techne Corp stock. As of the latest transaction made, Equitable Trust CO holds 8,973 shares of TECH stock, worth $675,756. This represents 0.05% of its overall portfolio holdings.

Number of Shares

8,973

Previous 9,931 9.65%

Holding current value

$675,756

Previous $711,000 0.84%

% of portfolio

0.05%

Previous 0.05%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$70.96 - $82.35 $67,979 - $78,891	-958 Reduced 9.65%	8,973 $717,000
Q1 2024 Apr 25, 2024	BUY	$65.98 - $77.09 $311,821 - $364,327	4,726 Added 90.8%	9,931 $699,000
Q4 2023 Jan 25, 2024	BUY	$52.83 - $78.22 $274,980 - $407,135	5,205 New	5,205 $401,000
Q2 2022 Jul 15, 2022	SELL	$322.67 - $449.65 $298,792 - $416,375	-926 Reduced 58.76%	650 $225,000
Q1 2022 May 06, 2022	SELL	$353.85 - $487.79 $113,585 - $156,580	-321 Reduced 16.92%	1,576 $682,000
Q4 2021 Jan 31, 2022	SELL	$456.15 - $525.06 $251,794 - $289,833	-552 Reduced 22.54%	1,897 $981,000
Q3 2021 Oct 26, 2021	SELL	$444.87 - $538.88 $68,509 - $82,987	-154 Reduced 5.92%	2,449 $1.19 Million
Q2 2021 Aug 03, 2021	SELL	$387.35 - $450.26 $317,239 - $368,762	-819 Reduced 23.93%	2,603 $1.17 Million
Q1 2021 May 14, 2021	SELL	$314.62 - $411.0 $558,135 - $729,114	-1,774 Reduced 34.14%	3,422 $1.31 Million
Q4 2020 Feb 12, 2021	BUY	$246.9 - $321.87 $7,653 - $9,977	31 Added 0.6%	5,196 $1.65 Million
Q2 2020 Aug 18, 2020	BUY	$185.43 - $279.56 $31,708 - $47,804	171 Added 3.42%	5,165 $1.36 Million
Q1 2020 May 21, 2020	BUY	$161.17 - $221.51 $804,882 - $1.11 Million	4,994 New	4,994 $947,000

Others Institutions Holding TECH

# of Institutions

608

Shares Held

152M

Call Options Held

171K

Put Options Held

56.9K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.95B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Equitable Trust CO with notifications on news.

Account

Equitable Trust CO Bio Techne Corp Transaction History